Cited by 224Diphtheria, Corynebacterium, and TetanusImmune responses and vaccinationsBacterial Infections and Vaccines

Insufficient protection for healthy elderly adults by tetanus and TBE vaccines

Hainz, Ursula, Jenewein, Brigitte, Asch, Esther, Pfeiffer, Karl-P., Berger, Peter, Grubeck-Loebenstein, Beatrix·2005·Vaccine

Abstract

Little information is available on post-vaccination antibody concentrations and the duration of protection in persons of more than 20 years of age. We, therefore, measured antibodies specific for tetanus (TT) or tick-borne encephalitis (TBE) virus in 734 adults (age 18-93 years, 382 females and 352 males) and evaluated these data in connection with the time point of the last vaccination against tetanus or TBE and age. This analysis revealed that the time of the last vaccination as well as age had highly significant effects on tetanus and TBE titers (p < 0.001). Our results show a strong decline in post-vaccination antibody concentrations with age, which sets in at the age of 40 in the case of tetanus, and is observed right throughout adult life in the case of TBE. Persons over 60 years of age frequently do not have protective antibody concentrations. We conclude that immunological responsiveness to vaccination decreases throughout adult life, and that conventional vaccination strategies designed for children and young adults cannot be uncritically applied in the elderly.

Integrity signals

Registry

Crossref · 10.1016/j.vaccine.2005.01.085

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The immune system changes with age in nearly every aspect, generally leading to weaker pathogen immunity.

    “The immune system changes with age in nearly every aspect, generally resulting in a decline in pathogen immunity with increased age.”

    From SARS-CoV-2, COVID-19 and the aging immune system (2021) · cites this paper as [6]

  • Ageing is associated with high morbidity and mortality from various infections and with substantially lower vaccine efficacy.

    “ageing is associated with high morbidity and mortality rates for various infections and significant reductions in vaccine efficacy1-6”

    From SARS-CoV-2, COVID-19 and the aging immune system (2021) · cites this paper as [6]

  • Vaccination of older individuals is only partially successful; generating new immune memory and boosting existing memory are less efficient than in childhood.

    “Attempts to improve immune competence through vaccination programs of older individuals have been only partially successful; generating immune memory to new antigens and boosting existing memory are less efficient than in childhood”

    From Successful and Maladaptive T Cell Aging (2017) · cites this paper as Hainz et al., 2005

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hainz, U., Jenewein, B., Asch, E., Pfeiffer, K.-P., Berger, P., & Grubeck-Loebenstein, B.
Affiliations
  • Austrian Academy of Sciences (AT)
  • Universität Innsbruck (AT)
Venue
Vaccine
Publisher
Elsevier BV
Published
2005-05
Volume
23
Issue
25
Pages
3232-3235
ISSN
0264-410X (ISSN-L)
OpenAlex
W2025821286
Cited by
224
References
8
Citations by year
2026: 5 · 2025: 7 · 2024: 6 · 2023: 13 · 2022: 12 · 2021: 18 · 2020: 9 · 2019: 6 · 2018: 7 · 2017: 14 · 2016: 6 · 2015: 8 · 2014: 9 · 2013: 12 · 2012: 9
FWCI
5.63
Type
journal article
Language
en
Open access
closed
Locations
  • Vaccine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Diphtheria, Corynebacterium, and Tetanus
  • Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
  • Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
Keywords
tetanus vaccine, tick-borne encephalitis vaccine, antibody titers, duration of protection, immunosenescence, older adults, vaccination strategies, seroprevalence
MeSH terms
Adolescent, Adult, Aged, Aged, 80 and over, Aging, Antibodies, Bacterial, Antibodies, Viral, Encephalitis, Tick-Borne, Enzyme-Linked Immunosorbent Assay, Female, Humans, Male, Middle Aged, Tetanus, Tetanus Toxoid, Viral Vaccines, Treatment Failure

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review